Kevin Lilly is the vice president of commercial operations at Carolina Precision Technologies. Before taking up this role, Kevin Lilly worked as a senior vice president of sales at the publicly traded company MiMedx Group (MDXG) from 2015 to 2019.
MiMedx is a biopharmaceutical company that was founded in 2008. The organization has its headquarters in Marietta, Georgia, and is seen as an industry leader in therapeutic biologics and advanced wound care. MDXG uses birth tissue, such as the placenta, umbilical cord, and amniotic sac, to create skin that can then be used to treat burn injury, diabetic foot ulcers, and other similar conditions. Birth tissue has flexible properties that allow it to conform and provide a protective cover around a wound region. This natural covering aids in tissue remodeling and restoration which then leads to faster recovery.
MiMedx acquires birth tissue donations from new mothers who delivered through Cesarean section. Using these donations, MDXG continues to advance medical research and find new ways to treat medical conditions.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.